Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted adenovirus vectors.

Hiroyuki Mizuguchi1, Takao Hayakawa

  • 1Project III, National Institute of Health Sciences, Osaka Branch, Fundamental Research Laboratories for Development of Medicine, Osaka 567-0085, Japan. mizuguch@nihs.go.jp

Human Gene Therapy
|December 22, 2004
PubMed
Summary

Recombinant adenovirus (Ad) vectors are widely used but face limitations in gene transfer efficiency and biodistribution. This review explores advances in developing targeted Ad vectors to overcome these challenges for improved gene therapy applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatic lipid quantity and quality in type 2 diabetes mellitus.

Frontiers in pharmacology·2026
Same author

Efficacy of intranasal adenovirus vector vaccine is attenuated by type I IFN-induced NK cell activation.

Molecular therapy. Advances·2026
Same author

Effects of cellular receptors on the vaccine efficacies of adenovirus vector-based vaccines following intramuscular and intranasal administration.

Scientific reports·2026
Same author

Liver-Specific Suppression of PLA2G6/iPLA<sub>2</sub>β Improves Glucose and Lipid Metabolism in High-Fat Diet-Fed Mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Extending a liver-based model to lung and intestine: a comparative study of CYP1A1 and CYP1A2 induction by cigarette smoke in human in vitro models.

Archives of toxicology·2026
Same author

Automated High-Throughput Raman Spectral Framework for Cellular Differentiation Monitoring.

Nano letters·2026

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Recombinant adenovirus (Ad) vectors are favored for gene therapy due to ease of construction, high titer production, and efficient transduction.
  • Limitations include inefficient gene transfer in cells lacking the coxsackievirus and adenovirus receptor (CAR) and broad biodistribution due to CAR's widespread expression.
  • These limitations hinder specific in vivo gene transfer applications.

Purpose of the Study:

  • To review recent advancements in developing targeted adenovirus vectors.
  • To discuss strategies for modifying Ad vector tropism to enhance gene transfer efficiency and specificity.
  • To highlight methods overcoming CAR-dependent and CAR-independent limitations.

Main Methods:

  • Modification of Ad capsid proteins, including addition of foreign ligands or fiber substitution.

Related Experiment Videos

  • Conjugation of Ad vectors with adaptor molecules like antibodies or fusion proteins.
  • Chemical modification of Ad vectors with targeting ligand-containing polymers.
  • Ablation of native Ad tropism combined with targeted modifications.

    • Main Results:

    • Targeted Ad vectors demonstrate improved tropism modification for enhanced gene therapy.
    • Strategies include altering capsid proteins, using adaptor molecules, and polymer conjugation.
    • These approaches aim to overcome CAR receptor limitations and control biodistribution.

    Conclusions:

    • Targeted Ad vectors represent a significant advancement in overcoming the limitations of conventional Ad vectors.
    • Modified Ad vectors offer enhanced specificity and efficiency for gene therapy and research.
    • Continued development of targeted Ad vectors is crucial for advancing gene transfer technologies.